Use of the next generation of tools to accelerate biosimilar & rare disease drug development webinar

April 26, 2018 | 4:00PM  -  5:00PM  (GMT+08:00) China Standard Time


Sponsors of biosimilar products continue to look for ways to accelerate biosimilar drug development in their race to the marketplace. To streamline biosimilar drug development more quickly, newer approaches have dealt with trial design in addition to protocol optimization and additional, non-traditional ways to identify patients more quickly. We developed two tools that have accelerated the biosimilar drug development process and these are discussed further in this webinar. 

  • Evidence Driven Design for Protocol Optimization
  • Infosario Design

This webinar is the fourth in the series of presentations for the companies targeting global biosimilars development and registration in the Western markets. In our previous webinars, attendees learned about pharmaceutical development and analytical characterization of biosimilars, selection of reference product, regulatory requirements and how to optimize clinical development.